Alamar Biosciences, Inc. (ALMR) Market Cap & Valuation Ratios
Alamar Biosciences, Inc. (ALMR) has a market cap of $2.1B and a price-to-sales ratio of 72.4, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · read by EquiReason
ALMRAlamar Biosciences, Inc.Follow ALMR — free
—
Price chart with a free account
- Market cap
- 2.1B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
Peers
scientific & technical instruments · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| ALMR | 2.1 | — | — | — | — | — | -46% | — |
| ESE | 6.0 | — | 4.7 | 24.6 | 3.3% | +27% | 16% | 8% |
| ST | 5.9 | 67.3 | 2.1 | 15.1 | 9.9% | +0.8% | 8% | 3% |
| CAMT | 5.5 | 115.7 | 10.6 | 41.3 | 2.3% | +12% | 26% | 13% |
| NOVT | 5.3 | 89.7 | 4.7 | 31.4 | 2.1% | +8% | 9% | 6% |
| VNT | 4.6 | 14.2 | 2.0 | 10.0 | 8.3% | +0.9% | 19% | 16% |
| BMI | 4.3 | 34.9 | 4.8 | 20.9 | 3.3% | -2% | 19% | 23% |
| ITRI | 3.8 | 14.7 | 2.0 | 12.7 | 10.0% | -6% | 13% | 13% |
| FEIM | 0.7 | — | 9.1 | 186.8 | -0.0% | +6% | 3% | 3% |
| MLAB | 0.7 | — | 3.3 | 18.3 | 7.3% | +3% | 9% | 4% |
| VPG | 0.7 | — | 2.0 | 23.6 | -1.1% | +11% | 3% | 2% |
| Median of these 10 | 51.1 | 4.0 | 22.2 | 3.3% | +5% | 11% | 7% |
.
Growth vs. price
each dot a company · hover or tap for valuesALMR and ESE and FEIM and MLAB and VPG have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Alamar Biosciences, Inc. — questions
- What is Alamar Biosciences, Inc.'s market cap?
- $2.1B.
- What is Alamar Biosciences, Inc.'s price-to-sales ratio?
- 72.4.
Every figure on this page comes from Alamar Biosciences, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.